RARE Investors Have Opportunity to Join Ultragenyx Pharmaceutical Inc. Fraud Investigation with the Schall Law Firm
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Ultragenyx and development partner Mereo BioPharma Group plc issued a press release on July 9, 2025, to announce that the 'randomized, placebo-controlled Phase 3 portion of the Orbit study evaluating UX143 (setrusumab) in pediatric and young adult patients with osteogenesis imperfecta (OI) is progressing toward a final analysis." The Company disclosed that this final analysis would occur "around the end of the year." Based on this news, shares of Ultragenyx fell by more than 25.1% on the next day.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Prediction: SharpLink's Ethereum Move Is Just the Beginning
Key Points A handful of publicly traded companies, including SharpLink Gaming, have now embraced the Ethereum treasury company model. Just like the Bitcoin treasury company model, it relies on raising money from investors to buy crypto. It remains to be seen if a strategy created for Bitcoin will be just as successful for Ethereum. 10 stocks we like better than Ethereum › Something very interesting is going on with Ethereum (CRYPTO: ETH) right now. Small, relatively unknown companies are starting to add Ether, the native coin of the Ethereum blockchain, to their balance sheets as part of a new strategy designed to lift their stock market valuations. And so far, it's working. Case in point: during the past 30 days, shares of SharpLink Gaming (NASDAQ: SBET) are up a whopping 150% (as of July 18). SharpLink Gaming has attracted so much attention with its new crypto strategy that it's almost certain to attract other companies as well. The Ethereum treasury company model In a very short time, SharpLink Gaming has become the largest corporate holder of Ether coins on the planet. It now holds 280,706 coins, worth about $960 million at recent prices. To put that figure into perspective, that's more Ether than even the nonprofit Ethereum Foundation holds. In early July, the company raised more than $400 million for its Ether war chest. After its latest buy in mid-July, it still has more than $250 million for future purchases, so it's likely that we'll be hearing more from SharpLink Gaming soon. If this strategy sounds familiar, that's because the Ethereum treasury company model is a replica of the Bitcoin (CRYPTO: BTC) treasury company model pioneered by Strategy (NASDAQ: MSTR), the company formerly known as MicroStrategy. The concept is very simple: Instead of using cash from operations to fund crypto purchases, you tap the capital markets for funding. Once you have this funding lined up, you go on a crypto buying spree. All of this works as long as the price of the cryptocurrency continues to go up. We've seen this work with Bitcoin, because the price of Bitcoin -- aside from a few pullbacks here and there -- has mostly gone up during the past 24 months. The same might be said for Ethereum, which is up 7% in 2025 (as of July 18) after registering losses for much of the year. It remains to be seen if Ethereum can deliver the same type of performance as Bitcoin, which is up 30% in the same period. The growth of Ethereum treasury companies For now, only a handful of publicly traded companies have adopted this strategy. Two other notable examples are Bitmine Immersion Technologies (NYSEMKT: BMNR) and Bit Digital (NASDAQ: BTBT). Both announced their pivots to this model in June. Now that the groundwork has been laid, it's easy to see how other companies could be tempted to jump in. The price of Ether is still only $3,600, which makes raising money from investors easier than raising money to buy Bitcoin at about $120,000. The lower barrier to entry is likely to be much more attractive for small-cap companies with relatively limited access to the capital markets. Should you invest in Ethereum treasury companies? Right now, I have mixed feelings about SharpLink Gaming, which is also a marketing partner for sports betting books and online casino operators. Just look at this chart, and you'll see why I think it's a risky gamble: In mid-2025, the company's stock had been flatlining. Nothing it did could get its stock price up. Until, of course, it latched on to the idea of investing in Ethereum. And I'm not very enthusiastic about Bitmine Immersion Technologies, either. Granted, it now has renowned investment strategist Tom Lee of Fundstrat as its chairman. That gives it a lot of power to reach out to investors for more capital. But what in the world is a Bitcoin mining company doing buying Ether? It doesn't make any sense to me. We can ask the same about Bit Digital, which is now winding down its Bitcoin mining operations. How can you be an evangelist for Ethereum when your core DNA is rooted in Bitcoin? That's why I'm starting to appreciate Strategy more and more these days. While Michael Saylor, the founder and executive chairman of the company, can be a bit over the top in his predictions, he's a strong evangelist for Bitcoin. I get the impression that, from the moment he wakes up to the moment he goes to bed, he's thinking about Bitcoin. That's the type of person I want running a crypto treasury company. So before you invest in an Ethereum treasury company, make sure you do your due diligence. Only a small handful of them may ever turn into long-term plays worthy of your investment. Should you invest $1,000 in Ethereum right now? Before you buy stock in Ethereum, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Ethereum wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $652,133!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,056,790!* Now, it's worth noting Stock Advisor's total average return is 1,048% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 15, 2025 Dominic Basulto has positions in Bitcoin and Ethereum. The Motley Fool has positions in and recommends Bitcoin and Ethereum. The Motley Fool has a disclosure policy. Prediction: SharpLink's Ethereum Move Is Just the Beginning was originally published by The Motley Fool Sign in to access your portfolio
Yahoo
2 hours ago
- Yahoo
Piper Sandler Initiates Coverage of National Energy Services Reunited (NESR) Stock With an Overweight Rating
National Energy Services Reunited Corp. (NASDAQ:NESR) is one of the Best Beaten Down Stocks to Buy Now. Piper Sandler initiated coverage of the company's stock with an 'Overweight' rating and a price objective of $11, as reported by The Fly. Notably, the firm expects a challenging backdrop for US land and is expecting a persistent negative rate-of-change environment for the balance of 2025, with the decline in U.S. land rig count. However, National Energy Services Reunited Corp. (NASDAQ:NESR) highlighted that operational execution was strong across Q1 2025, thanks to the continued improved processes, streamlined procedures, and reinforced internal controls. A drilling rig in action, operated by an oilfield services team. Despite the global economic headwinds, National Energy Services Reunited Corp. (NASDAQ:NESR) believes that conditions in the MENA region are supportive of growth, and it is focused on core strategic priorities. These include reporting profitable revenue growth, enhancing execution efficiency, commercializing new technology, as well as improving debt reduction and working capital efficiency to help long-term financial performance. National Energy Services Reunited Corp. (NASDAQ:NESR)'s net debt to adjusted EBITDA ratio was below 1.0, ending Q1 2025 at 0.93 as of March 31, 2025. This reflects a significant improvement from 1.30 as of March 31, 2024. National Energy Services Reunited Corp. (NASDAQ:NESR) is one of the leading national oilfield services providers. While we acknowledge the potential of NESR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now Disclosure: None. This article is originally published at Insider Monkey.
Associated Press
3 hours ago
- Associated Press
EWTX Investors Have Opportunity to Join Edgewise Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--Jul 19, 2025-- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Edgewise Therapeutics, Inc. ('Edgewise' or 'the Company') (NASDAQ: EWTX ) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Edgewise reported data from the clinical trials on its drug candidate sevasemten on June 26, 2025. The Company claimed the results were positive but also disclosed that the FDA had 'deemed the CANYON data alone insufficient for an accelerated approval.' Based on this news, shared of Edgewise fell by 8.86% on the same day. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at or by email at [email protected]. The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics. View source version on CONTACT: The Schall Law Firm Brian Schall, Esq. 310-301-3335 [email protected] KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA INDUSTRY KEYWORD: CLASS ACTION LAWSUIT PROFESSIONAL SERVICES LEGAL SOURCE: The Schall Law Firm Copyright Business Wire 2025. PUB: 07/19/2025 06:58 PM/DISC: 07/19/2025 06:57 PM
